NCT01588522 2025-05-28
Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for the Treatment of Chemotherapy-Induced Alopecia
BPGbio
Phase 1 Completed
Clinical Trials
8 trialsNCT00486512 2020-09-03
Chemoprevention of Colorectal Adenomas
Colotech A/S
Phase 3 Terminated
NCT00055263 2009-07-28
A New Formulation of Calcitriol (DN-101) in Patients With Advanced Malignancies
Novacea
Phase 1 Completed
NCT00043576 2009-03-12
ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
Novacea
Phase 2/3 Unknown
NCT00273338 2007-11-06
DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])
Novacea
Phase 3 Terminated
NCT00536770 2007-11-06
A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer
Novacea
Phase 2 Suspended
NCT00066885 2007-05-07
Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer
Novacea
Phase 1/2 Completed
NCT00285675 2006-05-31
Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004
Novacea
Phase 2 Unknown